⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL826103 | 0.93 | — | — | |
| SCHEMBL20529718 | 0.91 | ALDH1A1 (0.41) | — | |
| SCHEMBL20529724 | 0.91 | ALDH1A1 (0.41) | — | |
| SCHEMBL2795467 | 0.82 | — | — | |
| SCHEMBL7994399 | 0.76 | — | — | |
| SCHEMBL6589763 | 0.76 | — | — | |
| SCHEMBL176053 | 0.76 | — | — | |
| SCHEMBL8083435 | 0.73 | — | — | |
| SCHEMBL4018505 | 0.73 | — | — | |
| SCHEMBL7994428 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2358689-B9 | BENZOTHIAZOLE DERIVATIVES AS ANTICANCER AGENTS | TAKEDA PHARMACEUTICAL (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-2358689-B1 | BENZOTHIAZOLE DERIVATIVES AS ANTICANCER AGENTS | TAKEDA PHARMACEUTICAL (JP) | 2015-09-30 | — | — | EP | disclosed |
| US-9139589-B2 | Heteroaryls and uses thereof | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-9090601-B2 | Thiazole derivatives | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2015-07-28 | — | — | US | disclosed |
| CN-102300854-B | Benzothiazole Derivatives As Anticancer Agents | TAKEDA PHARMACEUTICAL | 2015-01-07 | — | — | CN | disclosed |
| EP-2123644-B1 | BENZOXAZEPINE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2014-12-17 | — | — | EP | disclosed |
| CN-104220065-A | Substituted prolines/piperidines as orexin receptor antagonists | EOLAS THERAPEUTICS INC | 2014-12-17 | — | — | CN | disclosed |
| US-8697874-B2 | Heterocyclic compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-04-15 | — | — | US | disclosed |
| US-8497274-B2 | Heterocyclic compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-07-30 | — | — | US | disclosed |
| US-8445509-B2 | Fused heterocyclic derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-05-21 | — | — | US | disclosed |
| US-20080064717-A1 | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme | ABBOTT LABORATORIES | 2008-03-13 | — | — | US | disclosed |
| WO-2008016192-A2 | FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-02-07 | — | — | WO | disclosed |
| WO-2007137107-A2 | INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME | ABBOTT LABORATORIES (US) | 2007-11-29 | — | — | WO | disclosed |
| EP-0969095-B1 | (S)-Hydroxynitrile lyases with improved substrate acceptance and uses thereof | DSM FINE CHEM AUSTRIA GMBH (AT) | 2004-09-29 | — | — | EP | disclosed |
| US-6319697-B1 | ENZYMATIC POLYPEPTIDE; FOR USE IN GENERATION OF PREFERENTIAL ENANTIMORPHS | DSM FINE CHEMICALS AUSTRIA GMBH (AT) | 2001-11-20 | — | — | US | disclosed |
| EP-0292564-B1 | PROCESS FOR PREPARING ALKOXYALKYL-SUBSTITUTED PHENOLS | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-4952736-A | REACTING ALKYL PHENOL, ALCOHOL, AND ALDEHYDE IN PRESENCE OF TERTIARY AMINE CATALYST | Idemitsu Petrochmeical Company, Limited (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0292564-A1 | PROCESS FOR PREPARING ALKOXYALKYL-SUBSTITUTED PHENOLS | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1988-11-30 | — | — | EP | disclosed |
| US-4578482-A | Process for preparing prostacyclins | TEIJIN LIMITED (JP) | 1986-03-25 | — | — | US | disclosed |
| EP-0113577-A1 | Process for preparing prostacyclins | TEIJIN LIMITED (JP) | 1984-07-18 | — | — | EP | disclosed |